Incyte (INCY) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -0.31% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | -0.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.98% |
| Dec 31, 2025 | -0.38% |
| Sep 30, 2025 | 3.72% |
| Jun 30, 2025 | 3.45% |
| Mar 31, 2025 | 1.63% |
| Dec 31, 2024 | 1.79% |
| Sep 30, 2024 | 4.03% |
| Jun 30, 2024 | 4.84% |
| Mar 31, 2024 | 6.58% |
| Dec 31, 2023 | 10.33% |
| Sep 30, 2023 | 13.73% |
| Jun 30, 2023 | 18.20% |
| Mar 31, 2023 | 21.84% |
| Dec 31, 2022 | 25.11% |
| Jun 30, 2022 | 28.61% |
| Mar 31, 2022 | 29.17% |
| Dec 31, 2021 | 31.31% |
| Sep 30, 2021 | 31.68% |
| Jun 30, 2021 | 35.20% |
| Mar 31, 2021 | 30.99% |
| Dec 31, 2020 | 29.15% |
| Sep 30, 2020 | 26.39% |
| Jun 30, 2020 | 27.51% |
| Mar 31, 2020 | 28.51% |
| Dec 31, 2019 | 31.07% |
| Jun 30, 2019 | 34.78% |
| Mar 31, 2019 | 54.01% |
| Dec 31, 2018 | 54.92% |
| Sep 30, 2018 | 53.48% |
| Jun 30, 2018 | 48.57% |
| Mar 31, 2018 | 48.58% |
| Dec 31, 2017 | 46.99% |
| Sep 30, 2017 | 48.57% |
| Jun 30, 2017 | 57.89% |
| Mar 31, 2017 | 70.98% |
| Dec 31, 2016 | 84.16% |
| Sep 30, 2016 | 190.45% |
| Jun 30, 2016 | 181.10% |
| Mar 31, 2016 | 142.62% |
| Dec 31, 2015 | 138.40% |
| Sep 30, 2015 | 138.02% |
| Jun 30, 2015 | 132.24% |
| Mar 31, 2015 | 134.80% |
| Dec 31, 2014 | 133.42% |
| Sep 30, 2014 | 131.36% |
| Jun 30, 2014 | 116.23% |
| Mar 31, 2014 | 98.61% |
| Dec 31, 2013 | 77.46% |